Background-The age association of cardiovascular disease may be in part because its metabolic risk factors tend to rise with age. Few studies have analyzed age associations of multiple metabolic risks in the same population, especially in nationally representative samples. We examined worldwide variations in the age associations of systolic blood pressure (SBP), total cholesterol (TC), and fasting plasma glucose (FPG). Methods and Results-We used individual records from 83 nationally or subnationally representative health examination surveys in 52 countries to fit a linear model to risk factor data between ages 30 and 64 years for SBP and FPG, and between 30 and 54 years for TC. We report the cross-country variation of the slope and intercept of this relationship.
C ardiovascular disease (CVD) rates tend to rise with age in most populations, although the age association of CVD varies across countries and has changed over time. [1] [2] [3] It is believed that this association is partly because major CVD risk factors including blood pressure, cholesterol, and diabetes rise with age, and possibly because risk factor effects accumulate over life course. 1 Despite this commonly held view, some studies have found that populations with low CVD risk, eg, some rural populations in developing countries, have attenuated age gradients of blood pressure and cholesterol in comparison with urban and industrialized populations, attributed in part to lower consumption of salt and animal products and lower body mass index. 4 -11 Most previous studies focused on a single risk factor and, with the notable exception of the Intersalt study, were in 1 or a small number of populations. To our knowledge, there is no quantitative analysis of the age association of multiple CVD risk factors across nationally representative samples from countries in different regions and at different stages of economic development.
Clinical Perspective on p 2211
We used health examination surveys in populations worldwide to conduct consistent cross-population analyses of the age associations of blood pressure, cholesterol, and glucose. We examined the age associations in young to middle ages, and how age association changes in older ages. Following the analyses of Intersalt data, 10 we also examined whether the age association slopes are correlated with average population risk factor levels. Finally, we examined whether all risk factors rise more or less steeply in the same populations, and whether the slopes are associated with national income.
Methods
Our analysis was on systolic blood pressure (SBP), serum total cholesterol (TC), and fasting plasma glucose (FPG), because these factors were measured in a larger number of surveys than other markers of risk such as low-density lipoprotein cholesterol or postprandial glucose.
Data Sources
The data for this analysis were deidentified individual records in 83 health examination surveys in 52 countries that all covered ages 30 to 64 with measured SBP, TC, and FPG. The details of the surveys included in the analysis are provided in online-only Data Supplement Table I . All surveys had data on men and women. Fifty-four surveys were national, and the other 29 covered large subnational regions (eg, 9 provinces in China). Of the latter group, 16 were from England and Scotland and were designed with all the features of a national survey; these surveys are labeled as subnational in online-only Data Supplement Table I because we considered United Kingdom as the parent country. We excluded 6 other surveys for reasons detailed in online-only Data Supplement Table I . All surveys had data on SBP, 32 on TC, and 22 on FPG. Fifty-two surveys were from low-and middle-income countries, and 31 were from high-income countries.
Statistical Analysis
We dropped 0.7% of participants for SBP, 0.3% for TC, and 0.6% for FPG, because they did not have information on age. When SBP was measured more than once (all but 1 survey), we dropped the first SBP measurement because it was significantly higher than subsequent ones, and we used the average of the other measurements as each participant's SBP. All analyses were done separately for men and women.
For each survey and risk factor, we estimated the slope and intercept of the linear relationship between risk factor and age by fitting a linear regression model to individual records of participants who were between 30 and 64 years of age for SBP and FPG, and between 30 and 54 years of age for TC. All analyses used survey sample weights when available. Hereafter, we refer to the coefficient of age in this linear regression as "slope" and to the regression constant as "intercept." We used 30 years as the start age because some surveys did not have measurement below this age, and there was indication that there may also be nonlinearity at Ͻ30 years, making earlier ages incomparable across surveys. We restricted the analysis to 64 and 54 years because the slope may significantly change in older ages, making the linear model inappropriate; exploratory analyses showed that slopes changed at a younger age for TC than for SBP and FPG. We examined the distributions of the slopes and intercepts across populations and report their descriptive statistics ( Figure 1) .
In each survey, we also calculated mean risk factor levels in 5-year age groups, ie, 30 to 34, 35 to 39, …, 85ϩ years and used these mean levels to calculate an age-standardized mean for men and women in each survey for ages 30 to 64 for SBP and FPG and 30 to 54 for TC; we used the world population in 2000 as the standard population. Thus, we created, separately by sex, a data set in which each observation was 1 survey, and the variables were the slope and the intercept of the age association and the age-standardized mean for the same age range. We fitted a simple linear regression, separately for each sex, with the slope as the dependent variable and the age-standardized mean as the independent variable. The dependent variable in this regression is a measure of how steep/shallow the age association is; the independent variable measures how low/high the risk factor level is in the population across ages. A previous analysis of Intersalt had used sample median risk factor level instead of the age-standardized mean. 10 We did not use sample median because the survey populations had different age distributions, which could affect the comparability of the median. We also considered regression models that included whether a country was high versus low and middle income, but did not include that variable in the final model because its coefficients were not statistically significant at the 0.05 level. We conducted a similar analysis with the intercept (at age 30 years) as the dependant variable. Both regressions included a country-level random intercept to account for repeated surveys in the same countries.
Because there is a simple linear relationship between the intercept and slope of age association and the age-standardized mean, at a constant age-standardized mean any change in the coefficient of slope is accompanied by a change in the opposite direction in the coefficient of intercept and vice versa. At the extreme, if change in age-standardized mean is only due to a change in intercept (ie, shifting the whole line up/down), then the coefficient of regression of slope on mean would on average be 0, and the coefficient of regression of intercept on mean would be 1.0. On the other hand, if the change in age-standardized mean is only due to a shift in slope (rotating the regression line around the same intercept), the coefficient of regression of the intercept on mean would be 0 and that of slope would be 1/[0.5ϫ(65Ϫ30)] or Ϸ0.06 for SBP and FPG.
To analyze risk factor patterns in older ages, we used surveys that had data Ͼ65 years of age: 38 surveys for SBP, 17 for TC, and 8 for FPG (online-only Data Supplement Table I ). We divided the surveys into tertiles of slope for SBP and to those below and above median slope for TC and FPG. In each tertile or median group, we estimated mean risk factor level for 5-year age groups across all surveys, adjusting for differences across surveys using a fixed-effects regression model.
All analyses were done using STATA 10 (StataCorp, College Station, TX).
Results

Age Associations of SBP, TC, and FPG
The distributions of slopes and intercepts for SBP, TC, and FPG are shown in Figure 1 . Slopes varied across surveys, with TC and FPG having larger interquartile ratios than SBP ( Figure 1A ). The intercepts at age 30 varied less than the slopes, with intercept interquartile ratios ranging from 30% of that of slope for male TC to 86% for female SBP ( Figure 1B Table II ). The lowest slope in our analysis (1.7 mm Hg per 10 years) was Ϸ2 to 3 times as large as the lowest Intersalt slopes, and the highest slope in our analysis was Ϸ10% lower than the highest Intersalt slope. 10 Table II) . SBP slopes and intercepts in high-income and low-and middle-income countries were generally similar (Table 1, Figure 2 ).
Median FPG slope was slightly higher among women than men (7.7 versus 6.1 mg/dL per 10 years of age); however, men had higher median intercept at age 30 than women (95. (Table 1,  online-only Data Supplement Table II ); the differences were not statistically significant, possibly because of the relatively small number of surveys with FPG data.
The age associations for TC had 2 salient features. First, the TC slopes were markedly higher in women than in men ( Figure 1A) , with medians being 15.1 mg/dL and 7.8 mg/dL per 10 years of age, respectively. In contrast, median intercept at age 30 of 185.9 mg/dL in women was lower than the 198.6 mg/dL median among men. Second, TC generally was higher at age 30 and rose more steeply with age in high-income populations than in low-and middle-income countries (Figure 2 The smallest intercepts at age 30 for men and women were in Samoa (Ͻ155 mg/dL), whereas the largest, Ͼ200 mg/dL for women and Ͼ215 mg/dL for men were in Germany BundesGesundheits survey 1998. TC slope and intercept were correlated with per capita availability of animal fats in the food supply (with use of data from the food balance sheets of the Food and Agriculture Organization of the United Nations), with correlation coefficients ranging 0.47 to 0.74 for intercept and slope in the 2 sexes. Although risk factor slopes and intercepts differed between men and women, they were moderately correlated across countries, with correlation coefficients ranging from 0.29 for SBP to 0.91 for FPG for slopes and from 0.79 for SBP to 0.95 for FPG for intercepts (Figure 2 ). There was little correlation among the slopes and intercepts across different risk factors (pairwise correlations ranged from Ϫ0.26 to 0.36), ie, at least some of the determinants of each risk factor vary across populations independently of those of other risk factors.
An important finding in some of the countries with multiple survey rounds over long periods was that age associations of risk factors have changed over time. For example, the age associations of SBP and TC became shallower over multiple rounds of US NHANES and England Health Survey for England, 12 whereas that of FPG became substantially steeper over multiple NHANES rounds (onlineonly Data Supplement Table II ). Figure 3 shows that on average there was a flattening of age-SBP relationship around age 70 years, especially among men. FPG and TC age associations reversed in older ages (Ϸ55-60 for TC and 60 -65 for FPG), leading to lower levels in older ages than in middle ages. The FPG reversal was more modest for those surveys with below-median slope. In secondary analyses, we tested this flattening or reversal of age association at older ages in individual surveys by fitting a series of 2-peice linear regressions to those surveys that had data Ͼ65 years. This analysis showed that SBP continued to rise with age beyond 65 years in some surveys, whereas the rise became more attenuated or stopped in others. TC and FPG either increased at a slower rate or began to decline in older ages in most surveys.
Relationship Between Slope and Average Risk Factor Level in the Population
The strongest relationship between slope and agestandardized mean was seen for FPG with the regression coefficient being 0.21 for each decade of life (95% CI 0.12, 0.29) for men and 0.28 (95% CI 0.17, 0.39) for women ( Table  2) . In other words, populations that had 10 mg/dL higher age-standardized mean FPG were those in which FPG rose by an additional 2.1 and 2.8 mg/dL for each decade of age for men and women, respectively. Mirroring this, the coefficients of the regression of intercept at 30 on age-standardized mean FPG were 0.72 (95% CI 0.60, 0.83) for men and 0.64 (95% CI 0.49, 0.80) for women, which was smaller than those of SBP and TC (Table 2) . Together, these results indicate that differences in slope account for about one-third to one-half of the variations in age-standardized mean FPG across populations. Table II for numeric information for all surveys. SBP indicates systolic blood pressure; TC, total cholesterol; and FPG, fasting plasma glucose.
higher, by age 65, the Samoans would have a mean FPG that is higher by 80 to 88 mg/dL. SBP slope had the weakest association with age-standardized mean SBP, with a regression coefficient of 0.09 (95% CI 0.04, 0.15) for each decade of life for men and 0.09 (0.04, 0.14) for women. Consequently, SBP intercept had the largest association with its age-standardized mean among the 3 risk factors, with regression coefficients being 0.86 for women and men (Table 2) . 10 
Discussion
Our analysis of health examination surveys found that the age association of 3 major CVD risk factors, characterized by their intercept at age 30 years and slope in the subsequent decades of life, varied substantially among different populations. SBP had the smallest variation in slope relative to that of its intercept at age 30 years, and FPG had the opposite pattern. In other words, more of the cross-population differences in SBP occurred by age 30 in comparison with those of FPG which occurred mostly in adult life. We also found that the rise in SBP, TC, and FPG with age generally became attenuated or even reversed in older ages, as hypothesized in previous studies using more limited data. [13] [14] [15] The age at which change in slope occurred was smallest for TC (Ϸ55-60 years) and largest for SBP (Ϸ65-70 years). The reasons for flattening or reversal in older ages requires further investigation and may include selective early mortality among those with high risk factor levels, increased use of medication in older ages, 16, 17 or possibly cohort effects.
Previous studies, using samples from specific communities and cohorts, found that some communities had flat or shallow age associations for these 3 risk factors. 4 -11 However, some of these communities were selected specifically because they had low CVD risk or diets that were low in salt or animal products, and thus, by design, were not representative of national populations. None of the populations in our data had flat SBP age curves, possibly because national populations (versus smaller individual communities) are all affected by major determinants of SBP, especially salt intake. Some populations in our analysis had shallow age associations for FPG in both sexes and for TC in men.
Western high-income countries had higher slopes and intercepts for TC, especially in surveys before 2000, possibly because TC slope is affected by intake of animal fats, often associated with higher income. 18, 19 However ,TC slope declined in later surveys in high-income countries, possibly because of changes in diet or an increase in the use of statins in middle-aged and older people. There was no association between national income and the slopes of SBP and FPG. This may be because salt intake, a major determinant of SBP in populations, 11, 20, 21 is determined more by cultural and geographical factors than by national income. Furthermore, high-income countries may have higher coverage of blood pressure screening and antihypertensive drug use which would help attenuate the age association of SBP. There may also be an independent effect of aging on SBP, eg, because of vascular stiffness, which would lead to some similarities across populations. 22 This does not explain the nearly flat age association in some previous studies such as Intersalt. 4, 6, 10 We found the largest FPG slopes in countries in the Middle East and Oceania, which also have some of the highest body mass index levels in the world. 23 The age gradients of blood glucose and diabetes are influenced by body weight and body composition, although an independent age effect has also been observed. 24 -30 Similarly, between late-1970s and mid2000s, when mean body mass index in the United States increased, FPG age association shifted from one of the shallowest to one of the steepest worldwide.
Men and women in the same populations were generally on the low or high side of the distribution of slopes, but slopes tended to be higher among women than men, especially for TC, with the opposite pattern for intercepts. Because the data for men and women are from the same surveys, differences in measurement methods are unlikely to account for this finding. We hypothesize 2 potential explanations for the differences in male-female intercept and slope for SBP, TC, and FPG. First, these differences may be a consequence of differences in dietary and environmental factors between men and women in the same country. [31] [32] [33] Second, the higher slope among women may be due to real physiological differences, eg, those associated with menopause. 34 It is well known that before menopause women have lower CVD rates and this sex difference narrows after menopause, 35, 36 but the evidence for the role of hormonal factors on postmenopausal increase in CVD risk factors remains limited and equivocal. [37] [38] [39] [40] [41] Understanding the role of dietary, environmental, and reproductive factors in male-female blood pressure, cholesterol, and glucose differences at various ages requires individual level follow-up data or at least surveys with consistent and comparable data on such determinants including time since menopause.
The strengths and innovations of this analysis include the inclusion of 3 major CVD risk factors; a relatively large number of surveys from high-income and low-and middleincome countries, as well; and estimation of slope and intercept by use of individual records. The limitations of our analysis include the fact that fewer surveys had measured TC and FPG than SBP; some regions of the world were underrepresented in the data, eg, Latin America; it was not possible to investigate age associations before age 30; and there were few countries with repeated surveys over a few decades. The lack of repeated surveys in most countries restricted our ability to examine cohort effects, which may be an important determinant of cross-sectional age patterns. For example, data from multiple rounds of NHANES, the only survey that covered Ͼ25 years, show that SBP, TC, and FPG had both age and cohort effects in the United States. Specifically, at any given age, SBP and TC were generally lower in later birth cohorts than in earlier ones; FPG was generally higher in later birth cohorts. A previous analysis used an age and cohort model on NHANES data and found a continuous decline in SBP levels and age slope in subsequent birth cohorts in the United States. 12 Median SBP decreased by 2.4 mmHg per decade of birth year which was still smaller than the age effect. The SBP decrease by birth cohort was larger in women than men. Results for TC were similar with median TC declining by 0.12 mmol/L per decade of birth year. 42 It is well established that for individuals and populations, CVD risk factors are affected by interactions of genetic factors, diet and adiposity, behavioral and psychosocial factors, and treatment access and utilization. On the basis of our findings, an important research need is to use individual records from longitudinal studies to examine how these risk factors change over life course, 43 especially in relation to dietary, behavioral, psychosocial, and healthcare determinants. For example, a recent analysis of data from multiple cohorts in the United Kingdom found that blood pressure rose through late adulthood, with declining slopes; some of the rise and the levels in younger ages were associated with body mass index. 44 Furthermore, repeated population health surveys with measurements of CVD risk factors would help examine how changes in factors like salt and animal fat intake, adiposity, and the use of antihypertensive drugs and statins influence the levels and age patterns of risk factors at the population level. Partial support for the analysis was provided by the Program on the Global Demography of Aging. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to submit manuscript.
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